Comparison 8. Aspirin versus direct oral anticoagulant (6 months): sensitivity analysis.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
8.1 Deep vein thrombosis	2	31	Risk Ratio (M‐H, Random, 95% CI)	0.95 [0.04, 20.33]
8.2 Pulmonary embolism	2	31	Risk Ratio (M‐H, Random, 95% CI)	Not estimable
8.3 Major bleeding	2	31	Risk Ratio (M‐H, Random, 95% CI)	0.95 [0.04, 20.33]